Evotec's high throughput screening of cellular and biochemical assays is conducted in 1,536-well plate format on three proprietary and fully integrated screening systems (EVOscreen™).
The open architecture of these high throughput screening platforms allows the incorporation of:
- Proprietary Insight FCS+plus readers
- Opera™ confocal cell imaging device for cellular assays
- Commercial multimode readers (e.g. EnVision™ readers)
- Various liquid handling devices
Evotec offers high throughput screening of its own 250,000 compound screening library and / or client libraries.
A typical high throughput screening project encompasses:
- The adaptation of the assay to a high throughput screening format
- Pilot testing of a sub-set of compounds
- Primary screening in singlicates with on-plate performance controls
- Statistical hit-identification
- Hit-confirmation
- IC50 profiling
- Secondary testing
- Structural verification of the hit-compounds and SAR analyses.
- All data is captured in a comprehensive written report submitted as part of the service offered
In addition Evotec offers screening services using FLIPR™ and ELISA technology.
For more information, please contact us at info@evotec.com